JP2020533966A5 - - Google Patents

Download PDF

Info

Publication number
JP2020533966A5
JP2020533966A5 JP2020510102A JP2020510102A JP2020533966A5 JP 2020533966 A5 JP2020533966 A5 JP 2020533966A5 JP 2020510102 A JP2020510102 A JP 2020510102A JP 2020510102 A JP2020510102 A JP 2020510102A JP 2020533966 A5 JP2020533966 A5 JP 2020533966A5
Authority
JP
Japan
Prior art keywords
influenza
influenza virus
virus surface
promoter
myceliophthora thermophila
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020510102A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020533966A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2018/056003 external-priority patent/WO2019038623A1/en
Publication of JP2020533966A publication Critical patent/JP2020533966A/ja
Publication of JP2020533966A5 publication Critical patent/JP2020533966A5/ja
Pending legal-status Critical Current

Links

JP2020510102A 2017-08-21 2018-08-09 Myceliophthora thermophila中でのフルワクチンの産生 Pending JP2020533966A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762547885P 2017-08-21 2017-08-21
US62/547,885 2017-08-21
PCT/IB2018/056003 WO2019038623A1 (en) 2017-08-21 2018-08-09 PRODUCTION OF AN INFLUENZA VACCINE IN MYCELIOPHTHORA THERMOPHILA

Publications (2)

Publication Number Publication Date
JP2020533966A JP2020533966A (ja) 2020-11-26
JP2020533966A5 true JP2020533966A5 (enExample) 2021-09-16

Family

ID=65438455

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020510102A Pending JP2020533966A (ja) 2017-08-21 2018-08-09 Myceliophthora thermophila中でのフルワクチンの産生

Country Status (9)

Country Link
US (2) US11738080B2 (enExample)
EP (1) EP3672630A4 (enExample)
JP (1) JP2020533966A (enExample)
KR (1) KR20200090143A (enExample)
CN (1) CN111315408A (enExample)
AU (1) AU2018319501A1 (enExample)
CA (1) CA3073646A1 (enExample)
IL (1) IL272568A (enExample)
WO (1) WO2019038623A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230313121A1 (en) * 2020-05-14 2023-10-05 Dyadic International (Usa), Inc. Modified filamentous fungi for production of exogenous proteins
CN117377752A (zh) * 2021-03-11 2024-01-09 二进国际(美国)有限公司 用于生产具有减少的或不含n-连接的糖基化的外源蛋白的遗传修饰的丝状真菌
CN119836469A (zh) 2022-05-20 2025-04-15 辉宝动物保健公司 使用真菌构建体产生病毒蛋白抗原

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE245199T1 (de) 1994-05-20 2003-08-15 Sinai School Medicine Behandlung von influenzavirus-infektion unter verwendung von antiviralen acylierung/palmitylierung von hemagglutinin hemmen
ATE286136T1 (de) 1998-10-06 2005-01-15 Mark Aaron Emalfarb Transformationsystem in filamentösen fungiziden chrysosporium-wirtszellen
CN100420753C (zh) 2000-04-13 2008-09-24 马克·阿龙·埃马尔法尔布 丝状真菌领域的新的表达调节序列和表达产物
US8506967B2 (en) 2003-07-11 2013-08-13 Novavax, Inc. Functional influenza virus like particles (VLPs)
JP5060958B2 (ja) 2004-10-15 2012-10-31 イントレキソン コーポレーション 多価組換え抗原のコンビナトリアルベースの生産のための方法および組成物
EP2505651A3 (en) 2006-12-10 2013-01-09 Dyadic International, Inc. Isolated fungus with reduced protease activity
WO2008073490A1 (en) * 2006-12-12 2008-06-19 Carrington Laboratories Inc., Purification of influenza viral antigens
DK3421597T3 (da) 2009-03-16 2021-01-25 Danisco Us Inc System til chrysosporium lucknowense-proteinfremstilling
CA2787099A1 (en) 2009-03-30 2010-10-14 Anice C. Lowen Influenza virus hemagglutinin polypeptides containing stem domains, vaccines and uses thereof
WO2010150982A2 (ko) 2009-06-23 2010-12-29 한밭대학교 산학협력단 안전성이 뛰어난 인플루엔자 바이러스 백신용 재조합 헤마글루티닌 단백질 및 이를 함유하는 생분해성 plga 미립자의 제조 방법
CA2787974A1 (en) 2010-01-24 2011-07-28 Biological Mimetics, Inc. Immunogenic influenza composition
US20150087028A1 (en) * 2012-03-12 2015-03-26 Codexis, Inc. Cbh1a variants
US20130315955A1 (en) 2012-04-13 2013-11-28 Protein Sciences Corporation Stability and potency of hemagglutinin
EP3233924B1 (en) 2014-12-19 2019-05-15 Sanofi Pasteur Multimerization of recombinant protein by fusion to a sequence from lamprey
JP2019503168A (ja) 2015-12-02 2019-02-07 ビーエーエスエフ ソシエタス・ヨーロピアBasf Se Clr2活性が低減した糸状菌においてタンパク質を生産する方法

Similar Documents

Publication Publication Date Title
US20260001918A1 (en) Influenza virus vaccines and uses thereof
Margine et al. Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses
US20260048114A1 (en) Influenza virus vaccination regimens
Wohlbold et al. Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses
US9968670B2 (en) Influenza virus vaccines and uses thereof
CA2669485C (en) Papaya mosaic virus-based vaccines for influenza
JP2010533737A5 (enExample)
Klausberger et al. One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge
JP2009528987A5 (enExample)
JP2016516415A5 (enExample)
JP2013216685A5 (enExample)
RU2015146097A (ru) Получение вирусоподобных частиц вируса гриппа в растениях
Mallajosyula et al. Hemagglutinin sequence conservation guided stem immunogen design from influenza A H3 subtype
US20220403358A1 (en) Recombinant neuraminidase and uses thereof
Ravin et al. Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein
JP2023539356A5 (enExample)
CN101899461B (zh) 一种编码甲型流感病毒NP蛋白和M2e多肽的融合基因
Subathra et al. Evaluation of antibody response in mice against avian influenza A (H5N1) strain neuraminidase expressed in yeast Pichia pastoris
JP6978079B2 (ja) ウシ免疫不全ウイルスgagタンパク質を使用する組換えウイルス様粒子
Kesik-Brodacka et al. A universal flu vaccine
Ramly et al. Infectious salmon anaemia virus nuclear export protein is encoded by a spliced gene product of genomic segment 7
Qian et al. Secretion of truncated recombinant rabies virus glycoprotein with preserved antigenic properties using a co-expression system in Hansenula polymorpha
US9150620B2 (en) Vaccine against multitypes of avian influenza viruses and uses thereof
Gong et al. Identification of a linear epitope within domain I of Duck Tembusu virus envelope protein using a novel neutralizing monoclonal antibody
JP2020533966A (ja) Myceliophthora thermophila中でのフルワクチンの産生